Battelle and Northwest plan radioactive implant:
This article was originally published in Clinica
Executive Summary
Northwest Biotherapeutics and Battelle are to collaborate in developing a new type of radioactive implant for treating early-stage prostate cancer. Rather than encase radioactive isotopes in metallic "seeds", they plan to deliver them by infusing phase-changing liquid polymers into the prostate. This should simplify implantation and make treatment more effective, by allowing a wider range of isotopes to be used, say the companies.